HONG KONG, June 6 WuXi Biologics (Cayman) Inc priced its Hong Kong IPO at the top of expectations, a source with direct knowledge of the deal said on Tuesday, raising about $511 million in the largest new listing in the Asian financial hub in 2017.
( read original story …)